COVID19 - home | Infectious Diseases Data Observatory

Novel Coronavirus SARS-CoV-2

i

Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH

We host one of the largest international collections of clinical data related to COVID-19 with detailed individual patient data on more than 700,000 hospitalised individuals from over 1,200 institutions across over 45 countries. IDDO has facilitated the re-use of these data in 48 novel analyses to date.

COVID-19 data platform

IDDO and ISARIC are partners in this global collaboration that collates, harmonises and shares COVID-19 clinical data. By contributing and accessing data on the platform, you can promote research that informs clinical practice and the public health response.

Contribute data to the platform

See how data are being used

Access data from the platform

Our work on COVID-19

The platform enables responsible use of data, allowing researchers to address clinically important questions and generate new evidence that reduces the impact of COVID-19. IDDO has developed partnerships and resources to accelerate the global response to COVID-19 and to support high-quality research.

Living systematic review

COVID-19 medical product quality reports

Read more about our COVID-19 partners

Purple cell infected with covid-19

Explore the COVID-19 Clinical Research Coalition, a global research response to COVID-19 driven by the needs of low-resource settings.

Novel Coronavirus SARS-CoV-2

COVID-19 Clinical Research Coalition

Explore our COVID-19 publications

Cov2 causes COVID-19 credit: NIH

News

Children eating

Photo credit: Erly Tatontos, World Bank

Applications for RSTMH 2021 grants open

St Joseph Hospital in the DRC

Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries

IDDO and ISARIC partner to support data collection and analysis for COVID-19

New Clinical Data Report from ISARIC

Medics in clininc in PPE testing for COVID-19

Credit: World Bank Henisota Rafalia

New six-month report flags growing number of medical product quality concerns relating to COVID-19

Colorized scanning electron micrograph of a cell heavily infected with SARS-CoV-2 virus particles (yellow), isolated from a patient sample.

Credit: NIAID/NIH

New resources available for COVID-19

child's hand holding a pill

iStock-credit-borgogniels

New online tool to fill information gaps in substandard and falsified medicines

Photo shows COVID-19 testing in Madagascar

Photo: World Bank / Henitsoa Rafalia

COVID-19 Data Platform Data Access Committee - call for nominations

Colorized scanning electron micrograph of novel coronavirus SARS-CoV-2

Credit: NIAID/NIH

Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

CDISC Interim User Guide released

Novel Coronavirus SARS CoV 2

Credit: NIH Image Gallery

Global call for strategic planning for COVID-19 medical products

Photo of social media graphic encouraging people to pledge their support

Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries